Table GSummary of findings on nonpharmacologic treatment of adult treatment-resistant depression (TRD) with strength of evidence for Tier 1 (TRD) for KQ 4c, withdrawals due to adverse event

ComparisonOutcomeNumber of SubjectsStrength of Evidence*Findings
ECT vs. rTMSWithdrawals30Low1 fair cohort study: no difference in withdrawals between ECT and rTMS groups (P = NR).
ECT vs. shamWithdrawals0NANo eligible studies identified.
rTMS vs. shamWithdrawals337Insufficient7 trials (1 good, 6 fair): trials showed mixed results about withdrawals attributed to adverse events.
VNS vs. shamWithdrawals235Low1 good trial: VNS had greater withdrawals attributed to adverse events than sham (significance NR).
CBT vs. usual careWithdrawals0NANo eligible studies identified.

CBT = cognitive behavioral therapy; ECT = electroconvulsive therapy; NA = not applicable; NR = not reported; rTMS = repetitive transcranial magnetic stimulation; VNS = vagus nerve stimulation; vs. = versus

*

Strength of evidence is based on guidance provided in the AHRQ Methods Guide for Comparative Effectiveness Reviews; see text.

Good and fair designations relate to quality ratings for each study.

At least one Tier 2 and/or Tier 3 study addressed this comparison.

From: Executive Summary

Cover of Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults
Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults [Internet].
Comparative Effectiveness Reviews, No. 33.
Gaynes BN, Lux LJ, Lloyd SW, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.